-
1
-
-
0028887712
-
Benign prostatic hyperplasia: Medical and minimally invasive treatment options
-
Oesterling J. Benign prostatic hyperplasia: medical and minimally invasive treatment options. N Engl J Med. 1995;332: 99-109.
-
(1995)
N Engl J Med.
, vol.332
, pp. 99-109
-
-
Oesterling, J.1
-
2
-
-
0017076325
-
The use of alpha adrenergic blockers in benign prostatic obstruction
-
Caine M, Pfau A, Perlberg S. The use of alpha adrenergic blockers in benign prostatic obstruction. Br J Urol. 1976;48: 255-64.
-
(1976)
Br J Urol.
, vol.48
, pp. 255-264
-
-
Caine, M.1
Pfau, A.2
Perlberg, S.3
-
3
-
-
0017040902
-
A new look at bladder neck obstruction by the food and drug administration regulators: Guidelines for investigation of benign prostatic hypertrophy
-
Boyarsky S, Jones G, Paulson DF, Prout GRJ. A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg. 1976;68:29-32.
-
(1976)
Trans Am Assoc Genitourin Surg.
, vol.68
, pp. 29-32
-
-
Boyarsky, S.1
Jones, G.2
Paulson, D.F.3
Prout, G.R.J.4
-
4
-
-
0026591918
-
The american urological association symptom index for benign prostatic hyperplasia
-
Measurement Committee of the American Urological Association discussion 1564
-
Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. Measurement Committee of the American Urological Association. J Urol. 1992;148:1549-57; discussion 1564.
-
(1992)
J Urol.
, vol.148
, pp. 1549-1557
-
-
Barry, M.J.1
Fowler F.J., Jr.2
O'Leary, M.P.3
-
5
-
-
0026526408
-
Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine medical assessment program symptom indexes
-
Measurement Committee of the American Urological Association discussion 1564
-
Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol. 1992;148:1558-63; discussion 1564.
-
(1992)
J Urol.
, vol.148
, pp. 1558-1563
-
-
Barry, M.J.1
Fowler F.J., Jr.2
O'Leary, M.P.3
Bruskewitz, R.C.4
Holtgrewe, H.L.5
Mebust, W.K.6
-
6
-
-
0027283961
-
Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia
-
Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993;150:351-8.
-
(1993)
J Urol.
, vol.150
, pp. 351-358
-
-
Barry, M.J.1
Cockett, A.T.2
Holtgrewe, H.L.3
McConnell, J.D.4
Sihelnik, S.A.5
Winfield, H.N.6
-
7
-
-
0029939081
-
The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
-
Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA. The Hytrin community assessment trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. Urology. 1996; 47:159-68.
-
(1996)
Urology.
, vol.47
, pp. 159-168
-
-
Roehrborn, C.G.1
Oesterling, J.E.2
Auerbach, S.3
Kaplan, S.A.4
-
8
-
-
0028023946
-
Terazosin in the treatment of hypertension and symptomatic benign prostatic hyperplasia: A primary care trial
-
Guthrie R. Terazosin in the treatment of hypertension and symptomatic benign prostatic hyperplasia: a primary care trial. J Fam Pract. 1994;39:129-33.
-
(1994)
J Fam Pract.
, vol.39
, pp. 129-133
-
-
Guthrie, R.1
-
9
-
-
0030248565
-
Safety and efficacy of doxazosin in benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies
-
Roehrborn CG, Siegel RL. Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. Urology. 1996;48: 406-15.
-
(1996)
Urology.
, vol.48
, pp. 406-415
-
-
Roehrborn, C.G.1
Siegel, R.L.2
-
11
-
-
85047690119
-
Terazosin in the treatment of benign prostatic hyperplasia
-
Terazosin Benign Prostatic Hyperplasia Study Group
-
Brawer MK, Adams G, Epstein H. Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group. Arch Fam Med. 1993;2: 929-35.
-
(1993)
Arch Fam Med.
, vol.2
, pp. 929-935
-
-
Brawer, M.K.1
Adams, G.2
Epstein, H.3
-
12
-
-
0026460119
-
Use of terazosin in the medical treatment of benign prostatic hyperplasia: Experience in Italy
-
Di Silverio F. Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy. Br J Urol. 1992;70(suppl 1): 22-6.
-
(1992)
Br J Urol.
, vol.70
, Issue.SUPPL. 1
, pp. 22-26
-
-
Di Silverio, F.1
-
13
-
-
9044220970
-
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
-
Elhilali MM, Ramsey EW, Barkin J, et al. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia. Urology. 1996;47:335-42.
-
(1996)
Urology.
, vol.47
, pp. 335-342
-
-
Elhilali, M.M.1
Ramsey, E.W.2
Barkin, J.3
-
14
-
-
0026574697
-
A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
-
Lepor H, Auerbach S, Puras-Baez A, et al. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol. 1992;148:1467-74.
-
(1992)
J Urol.
, vol.148
, pp. 1467-1474
-
-
Lepor, H.1
Auerbach, S.2
Puras-Baez, A.3
-
15
-
-
9444268678
-
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
-
Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group
-
Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med. 1996;335:533-9.
-
(1996)
N Engl J Med.
, vol.335
, pp. 533-539
-
-
Lepor, H.1
Williford, W.O.2
Barry, M.J.3
-
16
-
-
0026488344
-
Terazosin in the treatment of benign prostatic hyperplasia: A multicentre, placebo-controlled trial
-
Lloyd SN, Buckley JF, Chilton CP, Ibrahim I, Kaisary AV, Kirk D. Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial. Br J Urol. 1992;70(suppl 1):17-21.
-
(1992)
Br J Urol.
, vol.70
, Issue.SUPPL. 1
, pp. 17-21
-
-
Lloyd, S.N.1
Buckley, J.F.2
Chilton, C.P.3
Ibrahim, I.4
Kaisary, A.V.5
Kirk, D.6
-
17
-
-
4243512170
-
Terazosin for the treatment of benign prostatic hyperplasia in the elderly: A 6-month double-blind study
-
Soloway M, Snyder J, Stone N, Laddu A. Terazosin for the treatment of benign prostatic hyperplasia in the elderly: a 6-month double-blind study. J Am Geriatr Soc. 1992;40: SA11.
-
(1992)
J Am Geriatr Soc.
, vol.40
-
-
Soloway, M.1
Snyder, J.2
Stone, N.3
Laddu, A.4
-
18
-
-
0028865153
-
Benign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?
-
Barry MJ, Williford WO, Chang Y, et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol. 1995; 154:1770-4.
-
(1995)
J Urol.
, vol.154
, pp. 1770-1774
-
-
Barry, M.J.1
Williford, W.O.2
Chang, Y.3
-
20
-
-
0028816195
-
A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia
-
Wasson JH, Reda DJ, Bruskewitz RG, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med. 1995;332:75-9.
-
(1995)
N Engl J Med.
, vol.332
, pp. 75-79
-
-
Wasson, J.H.1
Reda, D.J.2
Bruskewitz, R.G.3
Elinson, J.4
Keller, A.M.5
Henderson, W.G.6
|